Patients with primarily upper lobe distribution of emphysema seen on CT and low exercise capacity had improved mortality compared to medical therapy alone in the NETT trial.

In addition to becoming a surgical treatment option for emphysema patients, LVRS can also serve as an adjunct for adult and pediatric lung transplant patients pre-transplant and post-transplant.